Article Details

Pliant Therapeutics, Inc. (NASDAQ:PLRX) Given Average Rating of "Buy" by Brokerages

Retrieved on: 2021-04-05 13:18:45

Tags for this article:

Click the tags to see associated articles and topics

Pliant Therapeutics, Inc. (NASDAQ:PLRX) Given Average Rating of "Buy" by Brokerages. View article details on hiswai:

Excerpt

BlackRock Inc. now owns 855,573 shares of the company's stock worth $19,437,000 after acquiring an additional 371,294 shares during the period.

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up